Mettler-Toledo International (NYSE:MTD) Given New $1,450.00 Price Target at Wells Fargo & Company

Mettler-Toledo International (NYSE:MTD) had its target price lifted by equities researchers at Wells Fargo & Company from $1,400.00 to $1,450.00 in a research report issued on Monday,Benzinga reports. The firm presently has an “equal weight” rating on the medical instruments supplier’s stock. Wells Fargo & Company‘s price target would suggest a potential upside of 3.09% from the stock’s previous close.

MTD has been the subject of a number of other research reports. Morgan Stanley assumed coverage on Mettler-Toledo International in a research report on Tuesday, December 2nd. They issued an “equal weight” rating and a $1,550.00 price target for the company. Citigroup increased their target price on shares of Mettler-Toledo International from $1,600.00 to $1,700.00 and gave the stock a “buy” rating in a report on Monday, November 10th. Barclays lifted their price target on shares of Mettler-Toledo International from $1,350.00 to $1,600.00 and gave the company an “overweight” rating in a report on Monday, November 10th. Bank of America upgraded shares of Mettler-Toledo International from a “neutral” rating to a “buy” rating and set a $1,600.00 price target for the company in a research report on Monday. Finally, Evercore ISI raised their price objective on shares of Mettler-Toledo International from $1,275.00 to $1,400.00 and gave the company an “outperform” rating in a research report on Tuesday, October 7th. Six analysts have rated the stock with a Buy rating and seven have given a Hold rating to the company’s stock. Based on data from MarketBeat.com, Mettler-Toledo International currently has an average rating of “Hold” and a consensus price target of $1,445.83.

Mettler-Toledo International Trading Up 0.9%

NYSE MTD traded up $12.95 during trading hours on Monday, hitting $1,406.59. 43,687 shares of the company’s stock traded hands, compared to its average volume of 163,201. Mettler-Toledo International has a 52 week low of $946.69 and a 52 week high of $1,525.17. The firm has a market capitalization of $28.74 billion, a P/E ratio of 35.07, a P/E/G ratio of 4.50 and a beta of 1.40. The business’s fifty day moving average price is $1,402.13 and its two-hundred day moving average price is $1,293.95.

Mettler-Toledo International (NYSE:MTD) last issued its quarterly earnings results on Thursday, November 6th. The medical instruments supplier reported $11.15 earnings per share for the quarter, topping the consensus estimate of $10.62 by $0.53. The business had revenue of $1.03 billion for the quarter, compared to analysts’ expectations of $997.36 million. Mettler-Toledo International had a net margin of 21.20% and a negative return on equity of 426.96%. The company’s revenue was up 7.9% compared to the same quarter last year. During the same quarter last year, the company posted $10.21 EPS. Mettler-Toledo International has set its Q4 2025 guidance at 12.680-12.880 EPS and its FY 2025 guidance at 42.050-42.250 EPS. On average, sell-side analysts expect that Mettler-Toledo International will post 42.71 EPS for the current fiscal year.

Insider Buying and Selling at Mettler-Toledo International

In related news, CFO Shawn Vadala sold 1,895 shares of the business’s stock in a transaction dated Tuesday, November 11th. The stock was sold at an average price of $1,455.52, for a total value of $2,758,210.40. Following the sale, the chief financial officer directly owned 5,288 shares in the company, valued at approximately $7,696,789.76. The trade was a 26.38% decrease in their ownership of the stock. The transaction was disclosed in a filing with the Securities & Exchange Commission, which is accessible through this hyperlink. Also, insider Gerry Keller sold 236 shares of the stock in a transaction that occurred on Friday, November 21st. The shares were sold at an average price of $1,418.58, for a total value of $334,784.88. Following the transaction, the insider directly owned 159 shares of the company’s stock, valued at approximately $225,554.22. The trade was a 59.75% decrease in their ownership of the stock. The disclosure for this sale is available in the SEC filing. Over the last three months, insiders have sold 19,565 shares of company stock worth $28,683,737. Insiders own 0.77% of the company’s stock.

Institutional Inflows and Outflows

Institutional investors and hedge funds have recently modified their holdings of the business. Versant Capital Management Inc grew its stake in Mettler-Toledo International by 42.1% in the 3rd quarter. Versant Capital Management Inc now owns 27 shares of the medical instruments supplier’s stock worth $33,000 after acquiring an additional 8 shares in the last quarter. SJS Investment Consulting Inc. boosted its holdings in shares of Mettler-Toledo International by 2,700.0% in the third quarter. SJS Investment Consulting Inc. now owns 28 shares of the medical instruments supplier’s stock valued at $34,000 after purchasing an additional 27 shares during the period. Salomon & Ludwin LLC purchased a new position in Mettler-Toledo International during the 3rd quarter worth $43,000. Root Financial Partners LLC purchased a new position in Mettler-Toledo International during the 3rd quarter worth $42,000. Finally, WPG Advisers LLC bought a new stake in Mettler-Toledo International during the 1st quarter valued at $41,000. 95.07% of the stock is owned by hedge funds and other institutional investors.

About Mettler-Toledo International

Mettler-Toledo International Inc manufactures and supplies precision instruments and services in the Americas, Europe, Asia, and internationally. It operates through five segments: U.S. Operations, Swiss Operations, Western European Operations, Chinese Operations, and Other. The company’s laboratory instruments include laboratory balances, liquid pipetting solutions, automated laboratory reactors, real-time analytics, titrators, pH meters, process analytics sensors and analyzer technologies, physical value analyzers, density and refractometry, thermal analysis systems, and other analytical instruments; and LabX, a laboratory software platform to manage and analyze data generated from its instruments.